Company: LBRX
Filing Date: 2025-07-23
Form Type: DRS/A
Source: 0000950123-25-006557
Chunk: 15

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-07-23
Form: DRS/A
Chunk 15
---
per share; |

| • |     | shares of common stock issuable upon the exercise of outstanding stock options under                                 
 our 2017 Stock Incentive Plan, or the 2017 Plan, as of     , at a weighted-average exercise price of $    per share; |

8

| • |     | shares of common stock issuable upon the exercise of outstanding stock options       
 granted subsequent to     , at a weighted-average exercise price of $     per share; |

| • |     | shares of our common stock issuable upon the exercise of Class A common stock                                                                                                       
 warrants outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class A Warrants;” |

| • |     | shares of our common stock issuable upon the exercise of Class B common stock                                                                                                       
 warrants outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class B Warrants;” |

| • |     | shares of our common stock issuable to Maxim Partners LLC upon the exercise of                                                                                                                 
 common stock warrants outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Maxim Warrants;” |

| • |     | shares of our common stock issuable upon the exercise of common stock warrants                                                                                     
 outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Series B-1 
 Warrants;”                                                                                                                                                         |

| • |     | shares of our common stock issuable upon the exercise of common stock warrants                                                                                                  
 outstanding as of     , with an exercise price of $1.50 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—New Series B Warrants;” |

| • |     | shares of common stock reserved for future issuance under our 2025 Equity Incentive